FR2510606A1
(fr)
|
1981-07-30 |
1983-02-04 |
Berri Balzac |
Procede d'obtention de polyosides capsulaires, polyosides capsulaires ainsi obtenus et leur application a la preparation de vaccins
|
US5360897A
(en)
|
1981-08-31 |
1994-11-01 |
The University Of Rochester |
Immunogenic conjugates of streptococcus pneumonial capsular polymer and toxin or in toxiad
|
US4902506A
(en)
|
1983-07-05 |
1990-02-20 |
The University Of Rochester |
Immunogenic conjugates
|
ES2007937A6
(es)
|
1987-06-19 |
1989-07-01 |
Terumo Corp |
Jeringa de tipo medico y procedimiento para su fabricacion.
|
EP0399001B1
(fr)
|
1988-02-01 |
1994-07-27 |
Praxis Biologics, Inc. |
Epitopes de cellules t a titre de molecules porteuses pour vaccins conjugues
|
US5785973A
(en)
|
1988-02-01 |
1998-07-28 |
Praxis Biologics, Inc. |
Synthetic peptides representing a T-cell epitope as a carrier molecule for conjugate vaccines
|
CA2059692C
(fr)
|
1991-01-28 |
2004-11-16 |
Peter J. Kniskern |
Vaccin conjugue de polysaccharide contre les pneumocoques
|
US5314822A
(en)
|
1992-10-15 |
1994-05-24 |
Merck & Co., Inc. |
Method of clonal growth of Streptococcus pneumoniae
|
EP0616034B1
(fr)
|
1993-03-05 |
2004-10-20 |
Wyeth Holdings Corporation |
Plasmide pour la production de la protéine CRM et de la toxine de la diphthérie
|
US5565204A
(en)
|
1994-08-24 |
1996-10-15 |
American Cyanamid Company |
Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
|
US5681570A
(en)
|
1995-01-12 |
1997-10-28 |
Connaught Laboratories Limited |
Immunogenic conjugate molecules
|
FR2763244B1
(fr)
|
1997-05-14 |
2003-08-01 |
Pasteur Merieux Serums Vacc |
Composition vaccinale multivalente a porteur mixte
|
US7018637B2
(en)
|
1998-02-23 |
2006-03-28 |
Aventis Pasteur, Inc |
Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
|
GB9808932D0
(en)
|
1998-04-27 |
1998-06-24 |
Chiron Spa |
Polyepitope carrier protein
|
US6994986B2
(en)
|
1999-03-17 |
2006-02-07 |
The Board Of Trustees Of The Leland Stanford University |
In vitro synthesis of polypeptides by optimizing amino acid metabolism
|
JP2001190665A
(ja)
|
2000-01-14 |
2001-07-17 |
Terumo Corp |
シリンジ
|
AU2001249389A1
(en)
|
2000-03-22 |
2001-10-03 |
The Children's Hospital Of Philadelphia |
Modified blood clotting factors and methods of use
|
GB0108364D0
(en)
*
|
2001-04-03 |
2001-05-23 |
Glaxosmithkline Biolog Sa |
Vaccine composition
|
US7041479B2
(en)
|
2000-09-06 |
2006-05-09 |
The Board Of Trustess Of The Leland Stanford Junior University |
Enhanced in vitro synthesis of active proteins containing disulfide bonds
|
US6548276B2
(en)
|
2000-09-06 |
2003-04-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Enhanced in vitro synthesis of active proteins containing disulfide bonds
|
AU2001217678A1
(en)
|
2000-11-14 |
2002-05-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
In vitro protein synthesis using glycolytic intermediates as an energy source
|
DK2128246T3
(da)
|
2001-04-19 |
2014-05-12 |
Univ California |
Fremgangsmåder og sammensætninger til fremstilling af ortogonale tRNA-aminoacyl-tRNA-syntetasepar.
|
GB0115176D0
(en)
*
|
2001-06-20 |
2001-08-15 |
Chiron Spa |
Capular polysaccharide solubilisation and combination vaccines
|
EP1539948B1
(fr)
|
2002-08-19 |
2009-10-14 |
The Board of Trustees of The Leland Stanford Junior University |
Procedes ameliores de synthese de proteines in vitro
|
ATE445709T1
(de)
|
2002-10-16 |
2009-10-15 |
Scripps Research Inst |
Glycoproteinsynthese
|
AU2003291365B2
(en)
|
2002-11-07 |
2009-06-11 |
Synergy America, Inc. |
Compositions and methods for treating or preventing pneumococcal infection
|
FR2850106B1
(fr)
|
2003-01-17 |
2005-02-25 |
Aventis Pasteur |
Conjugues obtenus par amination reductrice du polysaccharide capsulaire du pneumocoque de serotype 5
|
WO2004067030A2
(fr)
|
2003-01-30 |
2004-08-12 |
Chiron Srl |
Vaccins injectables contre les multiples serogroupes du meningocoque
|
CA2518669C
(fr)
|
2003-03-13 |
2014-07-29 |
Glaxosmithkline Biologicals S.A. |
Procede de purification
|
US7341852B2
(en)
|
2003-07-18 |
2008-03-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods of decoupling reaction scale and protein synthesis yield in batch mode
|
US8048432B2
(en)
|
2003-08-06 |
2011-11-01 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Polysaccharide-protein conjugate vaccines
|
GB0323103D0
(en)
|
2003-10-02 |
2003-11-05 |
Chiron Srl |
De-acetylated saccharides
|
ES2532608T3
(es)
|
2003-11-20 |
2015-03-30 |
The Board Of Trustees Of The Leland Stanford Junior University |
Métodos mejorados de síntesis proteica in vitro
|
EA010837B1
(ru)
|
2004-03-25 |
2008-12-30 |
Зе Боард Оф Трастиз Оф Зе Лилэнд Стэнфорд Джуниор Юниверсити |
Повышение выхода экспрессии протеина в системах бесклеточного синтеза протеинов путём добавления антипенных присадок
|
GB0409745D0
(en)
|
2004-04-30 |
2004-06-09 |
Chiron Srl |
Compositions including unconjugated carrier proteins
|
GB0413868D0
(en)
|
2004-06-21 |
2004-07-21 |
Chiron Srl |
Dimensional anlaysis of saccharide conjugates
|
GB0421083D0
(en)
|
2004-09-22 |
2004-10-27 |
Glaxosmithkline Biolog Sa |
Purification process
|
AU2006214064B2
(en)
|
2005-02-18 |
2012-04-26 |
J. Craig Venter Institute, Inc. |
Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
|
GB0505996D0
(en)
|
2005-03-23 |
2005-04-27 |
Glaxosmithkline Biolog Sa |
Fermentation process
|
US7955605B2
(en)
|
2005-04-08 |
2011-06-07 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
US7709001B2
(en)
|
2005-04-08 |
2010-05-04 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
ME01334B
(me)
|
2005-04-08 |
2013-12-20 |
Wyeth Llc |
Polivalentni pripravak konjugata pneumokoknog polisaharida s proteinom
|
MX2007012337A
(es)
|
2005-04-08 |
2007-11-21 |
Wyeth Corp |
Separacion de contaminantes de polisacarido de streptococcus pneumoniae por manipulacion de ph.
|
US20070184072A1
(en)
|
2005-04-08 |
2007-08-09 |
Wyeth |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
US7312049B2
(en)
|
2005-06-14 |
2007-12-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Total amino acid stabilization during cell-free protein synthesis
|
MX2007016403A
(es)
|
2005-06-27 |
2008-03-07 |
Glaxosmithkline Biolog Sa |
Composicion inmunogenica.
|
JP5135220B2
(ja)
|
2005-09-01 |
2013-02-06 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス ゲーエムベーハー アンド カンパニー カーゲー |
血清群c髄膜炎菌を含む複数ワクチン接種
|
CA2626061A1
(fr)
|
2005-10-31 |
2007-05-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Synthese acellulaire de polypeptides lies a la membrane
|
GB0607088D0
(en)
|
2006-04-07 |
2006-05-17 |
Glaxosmithkline Biolog Sa |
Vaccine
|
AR058592A1
(es)
|
2005-12-22 |
2008-02-13 |
Glaxosmithkline Biolog Sa |
Vacuna
|
US8481054B2
(en)
|
2005-12-28 |
2013-07-09 |
The UAB Foundation |
Pneumococcal serotypes
|
WO2007087064A2
(fr)
|
2005-12-28 |
2007-08-02 |
The Uab Research Foundation |
Serotypes pneumococciques
|
DE102006002417A1
(de)
|
2006-01-18 |
2007-07-19 |
Kaindl Flooring Gmbh |
Verfahren zur Herstellung eines Verkleidungselements
|
EP3006041B1
(fr)
|
2006-03-17 |
2017-11-29 |
The Government of the United States of America, as represented by The Secretary, Department of Health and Human Services |
Procédé de préparation de conjugués immunogéniques multivalents complexes
|
US8414899B2
(en)
|
2006-04-11 |
2013-04-09 |
Yeda Research And Development Co. Ltd. |
Vaccines comprising multimeric HSP60 peptide carriers
|
TW200806315A
(en)
|
2006-04-26 |
2008-02-01 |
Wyeth Corp |
Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
|
US8808707B1
(en)
|
2006-05-08 |
2014-08-19 |
Wyeth Llc |
Pneumococcal dosing regimen
|
CA2657811C
(fr)
|
2006-06-29 |
2014-10-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Synthese acellulaire de proteines contenant des acides amines non naturels
|
EP2044194B1
(fr)
|
2006-06-30 |
2011-10-05 |
University Of Georgia Research Foundation, Inc. |
Hydrates de carbone d'anthrax, leur synthèse et leur utilisation
|
EP2056871B1
(fr)
|
2006-08-07 |
2017-11-15 |
President and Fellows of Harvard College |
Vaccins à base de matrice protéique et procédés de fabrication et d'administration de tels vaccins
|
MX2009003730A
(es)
|
2006-10-10 |
2009-04-22 |
Wyeth Corp |
Purificacion de polisacaridos de streptococcus pneumoniae tipo 3.
|
EP2086582B1
(fr)
|
2006-10-12 |
2012-11-14 |
GlaxoSmithKline Biologicals s.a. |
Vaccin comprenant une emulsion adjuvante huile en l'eau
|
GB0700136D0
(en)
|
2007-01-04 |
2007-02-14 |
Glaxosmithkline Biolog Sa |
Process for manufacturing vaccines
|
CA2673765A1
(fr)
|
2007-01-18 |
2008-07-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Synthese acellulaire amelioree de proteines actives contenant des liaisons bisulfure
|
MX2009010221A
(es)
|
2007-03-23 |
2009-10-19 |
Wyeth Corp |
Proceso abreviado de purificacion para la produccion de polisacaridos capsulares de streptococcus pneumoniae.
|
CN101883583B
(zh)
|
2007-06-26 |
2017-05-17 |
葛兰素史密丝克莱恩生物有限公司 |
含有肺炎链球菌荚膜多糖缀合物的疫苗
|
EP2222341B1
(fr)
|
2007-11-21 |
2015-02-25 |
University Of Georgia Research Foundation, Inc. |
Alcynes et procédés de réaction d'alcynes avec des composés dipolaires-1,3 fonctionnels
|
WO2009106085A1
(fr)
|
2008-02-28 |
2009-09-03 |
Nordic Vaccine A/S |
Compositions vaccinales comprenant des antigènes saccharidiques
|
WO2009109550A1
(fr)
|
2008-03-05 |
2009-09-11 |
Sanofi Pasteur |
Procédé de stabilisation d’un adjuvant contenant une composition de vaccin
|
CN102257155B
(zh)
|
2008-12-18 |
2016-03-02 |
惠氏有限责任公司 |
控制肺炎链球菌血清型19a多糖分子量的方法
|
RU2524436C2
(ru)
|
2008-12-18 |
2014-07-27 |
УАЙТ ЭлЭлСи |
Способ получения жидкой фракции, содержащей изолированные высокомолекулярные капсульные полисахариды streptococcus pneumoniae, и жидкая фракция, полученная таким способом
|
WO2010081110A1
(fr)
|
2009-01-12 |
2010-07-15 |
Sutro Biopharma, Inc. |
Système de double chargement pour l'introduction sélective d'acides aminés non natifs dans des protéines à l'aide d'une méthode de synthèse in vitro
|
JP5668049B2
(ja)
|
2009-03-24 |
2015-02-12 |
ノバルティス アーゲー |
髄膜炎菌h因子結合タンパク質および肺炎球菌糖結合体の組み合わせ
|
IT1398927B1
(it)
*
|
2009-06-25 |
2013-03-28 |
Consorzio Interuniversitario Per Lo Sviluppo Dei Sistemi A Grande Interfase Csgi |
Espressione batterica di un gene artificiale per la produzione di crm197 e derivati.
|
GB0917647D0
(en)
|
2009-10-08 |
2009-11-25 |
Glaxosmithkline Biolog Sa |
Expression system
|
WO2011075822A1
(fr)
|
2009-12-22 |
2011-06-30 |
Sanofi Pasteur Limited |
Compositions immunogènes et méthodes correspondantes
|
TW201136603A
(en)
|
2010-02-09 |
2011-11-01 |
Merck Sharp & Amp Dohme Corp |
15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
|
GB201003922D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
GB201003924D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
JP2011212183A
(ja)
|
2010-03-31 |
2011-10-27 |
Terumo Corp |
プレフィルドシリンジ
|
US9040253B2
(en)
|
2010-04-14 |
2015-05-26 |
Sutro Biopharma, Inc. |
Method for enhancing recombinant protein production by cell-free protein expression system
|
KR101609032B1
(ko)
|
2010-06-04 |
2016-04-04 |
와이어쓰 엘엘씨 |
스트렙토코커스 뉴모니아 백신 제제
|
US8912322B2
(en)
|
2010-07-29 |
2014-12-16 |
University Of Georgia Research Foundation, Inc. |
Aza-dibenzocyclooctynes and methods of making and using same
|
US9315468B2
(en)
|
2010-09-27 |
2016-04-19 |
University Of Georgia Research Foundation, Inc. |
Methods including latent 1,3-dipole-functional compounds and materials prepared thereby
|
AR084158A1
(es)
|
2010-12-10 |
2013-04-24 |
Merck Sharp & Dohme |
Formulaciones que mitigan la agregacion inducida por agitacion de composiciones inmunogenicas
|
EP2681196B1
(fr)
|
2011-03-04 |
2015-09-09 |
Life Technologies Corporation |
Composés et procédés de conjugaison de biomolécules
|
GB201103836D0
(en)
|
2011-03-07 |
2011-04-20 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
ES2864764T3
(es)
|
2011-05-11 |
2021-10-14 |
Childrens Medical Center |
Composición inmunogénica que presenta múltiples antígenos, y métodos y usos de la misma
|
WO2012163289A1
(fr)
|
2011-06-01 |
2012-12-06 |
厦门大学 |
Protéine de fusion comprenant le mutant non toxique de la toxine diphtérique crm197 ou un fragment de celui-ci
|
CN103764665A
(zh)
|
2011-06-28 |
2014-04-30 |
怀特黑德生物医学研究所 |
使用分选酶安装用于蛋白质连接的点击化学柄
|
EP2729178A1
(fr)
|
2011-07-08 |
2014-05-14 |
Novartis AG |
Procédé de ligature de la tyrosine
|
US20140294930A1
(en)
|
2011-08-04 |
2014-10-02 |
The Regents Of The University Of California |
STREPTOCOCCAL GlcNAc-LACKING GLYCOPOLYPEPTIDES, CELL WALL CARBOHYDRATES, STREPTOCOCCUS VACCINES, AND METHODS FOR MAKING AND USING THEM
|
TR201909110T4
(tr)
|
2011-09-14 |
2019-07-22 |
Glaxosmithkline Biologicals Sa |
Sakarit-protein glikokonjugatları yapmaya yönelik yöntemler.
|
MX354924B
(es)
*
|
2011-11-07 |
2018-03-22 |
Novartis Ag |
Molecula portadora que comprende un antigeno spr0096 y un spr2021.
|
SI3106176T1
(en)
|
2011-12-06 |
2018-04-30 |
Valneva Austria Gmbh |
Aluminum compounds for use in therapeutics and vaccines
|
KR102057217B1
(ko)
|
2012-06-20 |
2020-01-22 |
에스케이바이오사이언스 주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
RU2724840C2
(ru)
|
2012-08-16 |
2020-06-25 |
Пфайзер Инк. |
Способы гликоконъюгирования и композиции
|
EP3584255B1
(fr)
|
2012-08-31 |
2022-02-16 |
Sutro Biopharma, Inc. |
Acides aminés modifiés comprenant un groupe azido
|
CN102861326A
(zh)
|
2012-09-19 |
2013-01-09 |
天津康希诺生物技术有限公司 |
流脑多糖-蛋白质缀合疫苗及制备方法
|
CA2885625A1
(fr)
|
2012-10-02 |
2014-04-10 |
Glaxosmithkline Biologicals S.A. |
Conjugues saccharidiques non lineaires
|
US9650621B2
(en)
|
2012-10-12 |
2017-05-16 |
Sutro Biopharma, Inc. |
Proteolytic inactivation of select proteins in bacterial extracts for improved expression
|
KR20140075201A
(ko)
|
2012-12-11 |
2014-06-19 |
에스케이케미칼주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
KR20140075196A
(ko)
|
2012-12-11 |
2014-06-19 |
에스케이케미칼주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
ES2750525T3
(es)
|
2012-12-27 |
2020-03-26 |
Glaxosmithkline Biologicals Sa |
Procedimientos y composiciones relacionados con CRM197
|
GB201300707D0
(en)
|
2013-01-15 |
2013-02-27 |
Novartis Ag |
Compounds and processes
|
ITMI20130142A1
(it)
|
2013-01-31 |
2014-08-01 |
Biosynth Srl |
Vaccini glicoconiugati comprendenti unita' di base di un costrutto molecolare esprimente epitopi multipli incorporati
|
US9682984B2
(en)
|
2013-03-25 |
2017-06-20 |
Crystal Pharma S.A.U. |
Methods for the preparation of alcaftadine
|
US10190145B2
(en)
|
2013-04-19 |
2019-01-29 |
Sutro Biopharma, Inc. |
Expression of biologically active proteins in a bacterial cell-free synthesis system using bacterial cells transformed to exhibit elevated levels of chaperone expression
|
US20160107999A1
(en)
|
2013-05-24 |
2016-04-21 |
Synaffix B.V. |
Substituted azadibenzocyclooctyne compounds and their use in metal-free click reactions
|
US9764039B2
(en)
|
2013-07-10 |
2017-09-19 |
Sutro Biopharma, Inc. |
Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
CA2918076A1
(fr)
|
2013-07-11 |
2015-01-15 |
Novartis Ag |
Modifications de proteines chimioenzymatiques specifiques d'un site
|
US9840493B2
(en)
|
2013-10-11 |
2017-12-12 |
Sutro Biopharma, Inc. |
Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use
|
WO2015054590A2
(fr)
|
2013-10-11 |
2015-04-16 |
Sutro Biopharma, Inc. |
Arnt synthétases chargées d'amino-acides non naturels pour la production de pyridyl-tétrazine
|
HUE042421T2
(hu)
|
2013-10-11 |
2019-07-29 |
Sutro Biopharma Inc |
Nem természetes aminosav tRNS szintetázok a para-metilazid-L-fenilalaninhoz
|
US11160855B2
(en)
|
2014-01-21 |
2021-11-02 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
WO2015110940A2
(fr)
|
2014-01-21 |
2015-07-30 |
Pfizer Inc. |
Polysaccharides capsulaires de streptococcus pneumoniae et conjugués de ceux-ci
|
AU2015208821B2
(en)
|
2014-01-21 |
2017-11-02 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
SI3583947T1
(sl)
|
2014-01-21 |
2024-01-31 |
Pfizer Inc. |
Kapsularni polisaharidi streptococcus pneumoniae in njihovi konjugati
|
EP3097080A1
(fr)
|
2014-01-24 |
2016-11-30 |
SynAffix B.V. |
Procédé de cycloaddition d'un composé 1,3-dippole halogéné avec un (hétéro)cycloalkyne
|
WO2015112014A1
(fr)
|
2014-01-24 |
2015-07-30 |
Stichting Katholieke Universiteit |
Procédé de cycloaddition d'un composé hétéro(aryl) 1,3-dipole avec un (hétéro)cycloalkyne
|
US10597664B2
(en)
|
2014-01-31 |
2020-03-24 |
Fina Biosolutions, Llc |
Expression and purification of CRM proteins and related proteins, and protein domains
|
WO2015117093A1
(fr)
|
2014-01-31 |
2015-08-06 |
Fina Biosolutions, Llc |
Expression et purification de crm197 et de protéines associées
|
ES2930318T3
(es)
|
2014-02-14 |
2022-12-09 |
Pfizer |
Conjugados glucoproteicos inmunogénicos
|
WO2016004024A1
(fr)
|
2014-07-02 |
2016-01-07 |
Sutro Biopharma, Inc. |
Escherichia coli auxotrophe ayant une forte capacité de croissance et procédés d'utilisation
|
BR112017002183A2
(pt)
|
2014-08-05 |
2018-01-16 |
Glaxosmithkline Biologicals S.A. |
conjugado, composição farmacêutica, e, método para aumentar uma resposta imune em um mamífero
|
WO2016100889A1
(fr)
|
2014-12-19 |
2016-06-23 |
Sutro Biopharma, Inc. |
Optimisation de codons en vue d'améliorer les titres et la fidélité
|
US10648010B2
(en)
|
2015-01-08 |
2020-05-12 |
Sutro Biopharma, Inc. |
Formulations for drying bacterial cell extracts
|
PL3244917T3
(pl)
|
2015-01-15 |
2023-07-17 |
Pfizer Inc. |
Kompozycje immunogenne do zastosowania w szczepionkach przeciwko pneumokokom
|
BR112017026343A2
(pt)
|
2015-06-08 |
2019-11-19 |
Serum Inst Of India Private Ltd |
métodos para aperfeiçoar a adsorção de conjugados de proteína-polissacarídeo e formulação de vacina multivalente assim obtida
|
US20160370376A1
(en)
|
2015-06-17 |
2016-12-22 |
Andrei POLUKHTIN |
Compounds and methods for detection and isolation of biomolecules
|
US11135299B2
(en)
|
2015-06-17 |
2021-10-05 |
The Regents Of The University Of California |
Chemoselective modification of a carrier protein with a strained alkyne-labeled cargo agent
|
SI3313436T1
(sl)
|
2015-06-23 |
2021-09-30 |
Biological E Limited |
Multivalentno konjugirano pnevmokokno cepivo
|
KR102225282B1
(ko)
|
2015-07-21 |
2021-03-10 |
화이자 인코포레이티드 |
접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도
|
GB201518684D0
(en)
|
2015-10-21 |
2015-12-02 |
Glaxosmithkline Biolog Sa |
Vaccine
|
WO2017085586A1
(fr)
|
2015-11-20 |
2017-05-26 |
Pfizer Inc. |
Compositions immunogènes destinées à être utilisées dans des vaccins pneumococciques
|
CN108697815A
(zh)
|
2016-02-10 |
2018-10-23 |
辉瑞公司 |
具有egfr配体的治疗性纳米颗粒及其制备和使用方法
|
US20190070287A1
(en)
|
2016-02-12 |
2019-03-07 |
Virtici, Llc |
Tolerance therapeutic for treating polypeptide induced immune activation
|
EP3436061A4
(fr)
|
2016-03-31 |
2019-12-04 |
Liffey Biotech Limited |
Compositions de conjugués saccharide-polypeptide polymérisables et leurs procédés d'utilisation
|
GB201610599D0
(en)
|
2016-06-17 |
2016-08-03 |
Glaxosmithkline Biologicals Sa |
Immunogenic Composition
|
EP3269385A1
(fr)
|
2016-07-12 |
2018-01-17 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Composition de conjugués de polysaccharide-protéine pneumococcique
|
EP3296741B1
(fr)
|
2016-09-14 |
2019-08-21 |
Serum Institute of India Private Limited |
Essai à base de billes multiplexes pour la quantification de plusieurs types de protéines porteuses dans une composition vaccinale conjuguée multivalente
|
JP2019529497A
(ja)
|
2016-09-30 |
2019-10-17 |
バイオロジカル イー リミテッド |
多糖類−タンパク質コンジュゲートを含む多価肺炎球菌ワクチン組成物
|
US11951165B2
(en)
|
2016-12-30 |
2024-04-09 |
Vaxcyte, Inc. |
Conjugated vaccine carrier proteins
|
MA47223A
(fr)
|
2016-12-30 |
2019-11-06 |
Sutrovax Inc |
Conjugués polypeptide-antigène avec des acides aminés non naturels
|
HRP20220573T1
(hr)
|
2017-01-20 |
2022-06-10 |
Pfizer Inc. |
Imunogeni pripravci, namijenjeni upotrebi u pneumokoknim cjepivima
|
EP3576759A4
(fr)
|
2017-01-31 |
2020-11-11 |
Merck Sharp & Dohme Corp. |
Procédés de production de conjugués protéine-polysaccharide capsulaire à partir du sérotype 19f de streptococcus pneumoniae
|
CN110545852B
(zh)
|
2017-02-07 |
2023-05-26 |
韩美药品株式会社 |
非肽聚合物接头化合物、包含该接头化合物的缀合物及制备该接头化合物和缀合物的方法
|
CA3050120A1
(fr)
|
2017-02-24 |
2018-08-30 |
Merck Sharp & Dohme Corp. |
Amelioration de l'immunogenicite de conjugues de polysaccharide de streptococcus pneumoniae et de proteine
|
WO2018156468A1
(fr)
|
2017-02-24 |
2018-08-30 |
Merck Sharp & Dohme Corp. |
Formulations de vaccin pneumococcique conjugué
|
US20200061542A1
(en)
|
2017-02-24 |
2020-02-27 |
Merck Sharp & Dohme Corp. |
Methods for improving filterability of polysaccharide-protein conjugate reactions
|
US11219680B2
(en)
|
2017-02-24 |
2022-01-11 |
Merck Sharp & Dohme Corp. |
Polysaccharide-protein conjugates utilizing diphtheria toxin fragment B as a carrier
|
EP3621658A1
(fr)
|
2017-05-10 |
2020-03-18 |
Sanofi |
Linkers peptidiques et conjugués de cryptophycine, utiles en thérapie, et leur préparation
|
CA3074714A1
(fr)
|
2017-09-07 |
2019-03-14 |
Merck Sharp & Dohme Corp. |
Procedes de formulation de polysaccharides pneumococciques pour conjugaison a une proteine porteuse
|
CN111065388A
(zh)
|
2017-09-07 |
2020-04-24 |
默沙东公司 |
肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途
|
KR20200051005A
(ko)
|
2017-09-07 |
2020-05-12 |
머크 샤프 앤드 돔 코포레이션 |
폐렴구균 폴리사카라이드 및 면역원성 폴리사카라이드-담체 단백질 접합체에서의 그의 용도
|
MX2020002557A
(es)
|
2017-09-07 |
2020-07-13 |
Merck Sharp & Dohme |
Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina.
|
AU2018328037B2
(en)
|
2017-09-07 |
2024-03-07 |
Merck Sharp & Dohme Llc |
Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
|
US20200330579A1
(en)
|
2017-10-04 |
2020-10-22 |
Liffey Biotech Limited |
Saccharide-polypeptide conjugate compositions and methods of use thereof
|
SG11202005255PA
(en)
|
2017-12-06 |
2020-07-29 |
Merck Sharp & Dohme |
Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
|
AU2019215212A1
(en)
|
2018-02-05 |
2020-07-23 |
Sk Bioscience Co., Ltd. |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
AU2019215216A1
(en)
|
2018-02-05 |
2020-07-23 |
Sk Bioscience Co., Ltd. |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
KR20210005161A
(ko)
|
2018-04-30 |
2021-01-13 |
머크 샤프 앤드 돔 코포레이션 |
리오스피어로부터 스트렙토코쿠스 뉴모니아에 피막 폴리사카라이드 담체 단백질 접합체를 제조하는 방법
|
KR20210005158A
(ko)
|
2018-04-30 |
2021-01-13 |
머크 샤프 앤드 돔 코포레이션 |
스트렙토코쿠스 뉴모니아에 피막 폴리사카라이드 담체 단백질 접합체를 제조하는 방법
|
WO2019220304A1
(fr)
|
2018-05-14 |
2019-11-21 |
Tergene Biotech Pvt. Ltd. |
Vaccin conjugué de polysaccharide pneumococcique 15-valent
|